Jun 13, 2025
Abbott Declares 406th Consecutive Quarterly Dividend
May 27, 2025
Abbott Receives FDA Approval for Tendyne(TM), First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
May 15, 2025
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
May 07, 2025
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent
May 01, 2025
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
Apr 29, 2025
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
Apr 27, 2025
Abbott Highlights New AVEIR(TM) Data, Initiates Trial for the Company's Conduction System Pacing Technology
Apr 16, 2025
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
Mar 31, 2025
New Late-Breaking Data Reinforce Benefits of Abbott's TriClip(TM) for People With Leaky Tricuspid Heart Valve
Mar 26, 2025
Abbott Hosts Conference Call for First-Quarter Earnings
Feb 21, 2025
Abbott Declares 405th Consecutive Quarterly Dividend
Feb 04, 2025
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
Jan 22, 2025
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook
Jan 02, 2025
Abbott Hosts Conference Call for Fourth-Quarter Earnings
Dec 17, 2024
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
Dec 13, 2024
Abbott Increases Quarterly Dividend for 53rd Consecutive Year
Dec 07, 2024
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
Nov 25, 2024
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
Oct 24, 2024
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
Oct 16, 2024
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range